Ian D. Daugs

980 total citations
13 papers, 770 citations indexed

About

Ian D. Daugs is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Ian D. Daugs has authored 13 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Psychiatry and Mental health. Recurrent topics in Ian D. Daugs's work include Alzheimer's disease research and treatments (13 papers), Dementia and Cognitive Impairment Research (6 papers) and Prion Diseases and Protein Misfolding (4 papers). Ian D. Daugs is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Dementia and Cognitive Impairment Research (6 papers) and Prion Diseases and Protein Misfolding (4 papers). Ian D. Daugs collaborates with scholars based in United States, Argentina and United Kingdom. Ian D. Daugs's co-authors include Alex E. Roher, Tyler A. Kokjohn, Thomas G. Beach, Marwan N. Sabbagh, Chera L. Maarouf, Walter M. Kalback, Dean C. Luehrs, Eduardo M. Castaño, Mark R. Emmerling and Rebekah Patton and has published in prestigious journals such as PLoS ONE, American Journal Of Pathology and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Ian D. Daugs

13 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian D. Daugs United States	13	558	203	202	198	113	13	770
Rebekah Patton United States	9	606 1.1×	146 0.7×	191 0.9×	200 1.0×	60 0.5×	12	734
Luc Bracoud United States	11	410 0.7×	128 0.6×	133 0.7×	126 0.6×	137 1.2×	42	679
Sun-Ho Han South Korea	14	630 1.1×	175 0.9×	259 1.3×	400 2.0×	50 0.4×	17	1.0k
Gregory D. Van Vickle United States	6	501 0.9×	133 0.7×	170 0.8×	161 0.8×	55 0.5×	6	608
Barbara A. Isanski United States	7	713 1.3×	454 2.2×	151 0.7×	306 1.5×	140 1.2×	10	1.1k
Chera L. Maarouf United States	21	791 1.4×	301 1.5×	332 1.6×	352 1.8×	216 1.9×	34	1.3k
Annika Olsson Sweden	8	681 1.2×	396 2.0×	146 0.7×	286 1.4×	205 1.8×	9	932
Claudia Cicognola Sweden	13	560 1.0×	323 1.6×	190 0.9×	185 0.9×	157 1.4×	20	767
Hannah Tayler United Kingdom	11	467 0.8×	70 0.3×	259 1.3×	281 1.4×	76 0.7×	17	828
Shengjun Chang United States	6	590 1.1×	104 0.5×	147 0.7×	376 1.9×	64 0.6×	8	851

Countries citing papers authored by Ian D. Daugs

Since Specialization

Citations

This map shows the geographic impact of Ian D. Daugs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian D. Daugs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian D. Daugs more than expected).

Fields of papers citing papers by Ian D. Daugs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian D. Daugs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian D. Daugs. The network helps show where Ian D. Daugs may publish in the future.

Co-authorship network of co-authors of Ian D. Daugs

This figure shows the co-authorship network connecting the top 25 collaborators of Ian D. Daugs. A scholar is included among the top collaborators of Ian D. Daugs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian D. Daugs. Ian D. Daugs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Roher, Alex E., David H. Cribbs, Ronald C. Kim, et al.. (2013). Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy. PLoS ONE. 8(3). e59735–e59735. 32 indexed citations

Roher, Alex E., Chera L. Maarouf, Michael Malek‐Ahmadi, et al.. (2013). Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.. PubMed. 2(3). 187–207. 15 indexed citations

Kokjohn, Tyler A., Chera L. Maarouf, Ian D. Daugs, et al.. (2012). Neurochemical Profile of Dementia Pugilistica. Journal of Neurotrauma. 30(11). 981–997. 29 indexed citations

Kokjohn, Tyler A., Gregory D. Van Vickle, Chera L. Maarouf, et al.. (2011). Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(11). 1508–1514. 46 indexed citations

Maarouf, Chera L., Ian D. Daugs, Tyler A. Kokjohn, et al.. (2011). Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging. PLoS ONE. 6(11). e27291–e27291. 54 indexed citations

Beach, Thomas G., Chera L. Maarouf, Ian D. Daugs, et al.. (2011). Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease. BMC Geriatrics. 11(1). 3–3. 12 indexed citations

Hunter, Jesse M., William J. Bowers, Chera L. Maarouf, et al.. (2011). Biochemical and Morphological Characterization of the AβPP/PS/Tau Triple Transgenic Mouse Model and Its Relevance to Sporadic Alzheimer's Disease. Journal of Alzheimer s Disease. 27(2). 361–376. 13 indexed citations

Roher, Alex E., Chera L. Maarouf, Ian D. Daugs, et al.. (2011). Neuropathology and Amyloid-β Spectrum in a Bapineuzumab Immunotherapy Recipient. Journal of Alzheimer s Disease. 24(2). 315–325. 21 indexed citations

Roher, Alex E., Suzanne L. Tyas, Chera L. Maarouf, et al.. (2011). Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia. Alzheimer s & Dementia. 7(4). 436–444. 103 indexed citations

10.

Maarouf, Chera L., Ian D. Daugs, Tyler A. Kokjohn, et al.. (2010). The biochemical aftermath of anti-amyloid immunotherapy. Molecular Neurodegeneration. 5(1). 39–39. 38 indexed citations

11.

Maarouf, Chera L., Ian D. Daugs, Salvatore Spina, et al.. (2008). Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations. Molecular Neurodegeneration. 3(1). 20–20. 51 indexed citations

12.

Vickle, Gregory D. Van, Chera L. Esh, Ian D. Daugs, et al.. (2008). Tg-SwDI Transgenic Mice Exhibit Novel Alterations in AβPP Processing, Aβ Degradation, and Resilient Amyloid Angiopathy. American Journal Of Pathology. 173(2). 483–493. 25 indexed citations

13.

Roher, Alex E., Chera L. Esh, Tyler A. Kokjohn, et al.. (2008). Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease. Alzheimer s & Dementia. 5(1). 18–29. 331 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact